Gastrointestinal and Other Cancers Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma Aspirin, Biospecimen Collection, Placebo Administration, Questionnaire Administration, Rectal Biopsy NCT02965703 National Cancer Institute (NCI) Active, not recruiting
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful... Aspirin, Laboratory Biomarker Analysis, Placebo Administration, Questionnaire Administration NCT02521285 National Cancer Institute (NCI) Active, not recruiting
ASPirin Intervention for the REDuction of Colorectal Cancer Risk Aspirin, Placebo for Aspirin NCT02394769 Massachusetts General Hospital Active, not recruiting
CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts Ethanol, Normal saline, Paclitaxel + Gemcitabine admixture NCT03085004 Milton S. Hershey Medical Center Recruiting
Chemoprevention of Gastric Carcinogenesis Eflornithine, Eflornithine placebo NCT02794428 Vanderbilt-Ingram Cancer Center Active, not recruiting
Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric... Curcumin, Laboratory Biomarker Analysis, Placebo Administration, Quality-of-Life Assessment NCT02782949 National Cancer Institute (NCI) Active, not recruiting
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Pharmacological Study, Questionnaire Administration NCT03278925 National Cancer Institute (NCI) Active, not recruiting
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid NCT02772003 National Cancer Institute (NCI) Active, not recruiting
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Erlotinib, Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Quality-of-Life Assessment NCT02273362 National Cancer Institute (NCI) Active, not recruiting
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis Placebo Administration, Questionnaire Administration, Simvastatin NCT02968810 National Cancer Institute (NCI) Active, not recruiting

Pages